Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

RTTNews | 1041 days ago
Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

(RTTNews) - Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Thursday that the U.S. Food and Drug Administration (FDA) has accepted an Investigational New Drug (IND) application for the company's HT-001 therapeutic for the treatment for rash and skin disorders associated with epidermal growth factor receptor (EGFR) inhibitor therapy.

EGFR inhibitors are critical therapeutic agents for the treatment of non-small cell lung cancer (NSCLC), pancreatic cancer, colorectal cancer, squamous-cell carcinoma of the head and neck, and breast cancer.

The company said this trial brings us one step closer to a new treatment option for underserved cancer patients as there is no specific treatment currently approved for the treatment of skin toxicities associated with EGFRi therapies.

The company added it will advance HT-001 into the clinical phase as it is a key treatment in the onco-dermatology space and anticipates beginning the Phase 2a trial in the first quarter of 2023.

read more
Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Monday it has submitted a request for a Pre-Investigational New Drug (IND) meeting to the U.S. Food and Drug Administration (FDA) to discuss the proposed drug development program for HT-KIT, a new molecular entity, for the treatment of advance systemic mastocytosis (AdvSM), a rare aggressive form of cancer.
RTTNews | 785 days ago
Swiss Market Ends On Firm Note

Swiss Market Ends On Firm Note

After languishing in negative territory till well past mid afternoon on Tuesday, the Switzerland market recovered in the final hour of the day's session to settle on a firm note.
RTTNews | 4h 24min ago
European Stocks Close Weak Despite Late Recovery

European Stocks Close Weak Despite Late Recovery

European stocks closed lower on Tuesday and most of the markets in the region dropped to multi-week lows before regaining some lost ground, as worries about the potential impact of U.S. government shutdown and growth concerns due to tariffs forced investors to tread cautiously with regard to riskier assets.
RTTNews | 4h 50min ago
Bay Street Likely To Open With Negative Gap

Bay Street Likely To Open With Negative Gap

Sharply lower Canadian and U.S. futures and weak commodity prices point to a gap down opening on Bay Street Tuesday morning. The focus will be on the Federal Budget to be presented by Canadian Prime Minister Mark Carney today.
RTTNews | 8h 58min ago
Uber Q3 Profit Surges On Higher Trips, Sees Growth In Q4; But Stock Drops

Uber Q3 Profit Surges On Higher Trips, Sees Growth In Q4; But Stock Drops

Uber Technologies, Inc. reported Tuesday significantly higher profit in its third quarter as revenues beat market estimates, benefited by strong growth in trips. Bookings also were higher than last year, and the ride-hailing and food delivery company issued fourth-quarter outlook, expecting a growth. Meanwhile, the shares were losing around 5 percent in the pre-market activity.
RTTNews | 9h 27min ago
FTSE 100 Drifts Lower; Miners Among Notable Losers

FTSE 100 Drifts Lower; Miners Among Notable Losers

The U.K. market is down in negative territory on Monday, weighed down by losses in the mining sector. The mood remains quite cautious amid concerns about global economic growth as several central banks, including the Federal Reserve and the European Central Bank signaling that further interest rate cuts are unlikely in the coming months.
RTTNews | 10h 19min ago